Ulcerative Colitis Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Pfizer, AbbVie, Eli Lilly, Janssen, Reistone, Landos Biopharma, Arena Pharma

The Ulcerative Colitis Market size was ~USD 6,900 million in 2022, which is expected to grow by 2032. As per DelveInsight, the Ulcerative Colitis Market is anticipated to evolve immensely in the coming years owing to the rise in healthcare spending across the world, the launch of new therapies, and the increase in the number of cases of Ulcerative Colitis.

Major Pharma giants are thoroughly working toward the development of new treatment therapies for this indication, in order to provide better relief for the symptoms and hence improve the Quality of life (QoL) of patients with Ulcerative Colitis. Companies like AbbVie [Skyrizi (Risankizumab)], Eli Lilly and Company [Mirikizumab (LY-3074828)], Arena Pharmaceuticals [Etrasimod], Janssen (Johnson & Johnson) [Tremfya (Guselkumab)], InDex Pharmaceuticals [Corbitolimod] and several others are developing therapies which are in the clinical development stage for Ulcerative Colitis.

DelveInsight's "Ulcerative Colitis Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Ulcerative Colitis Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Ulcerative Colitis therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Ulcerative Colitis treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Ulcerative Colitis: An Overview
inflammation of the digestive tract. The exact cause of IBD is unknown, but it is the result of a defective immune system. Two major types of IBD are Ulcerative Colitis (UC) and Crohn's Disease (CD). Ulcerative Colitis is limited to the colon or large intestine. CD, on the other hand, can involve any part of the gastrointestinal tract from the mouth to the anus. Approximately 10% of cases of IBD exhibit the features of both CD and UC. These are typically known as Indeterminate Colitis (IC).

There are different types of Ulcerative Colitis, categorized by the cause of the disease: Ulcerative proctitis, Proctosigmoiditis, Left-sided colitis (also limited or distal colitis), pancreatitis, and Extensive Colitis. Symptoms of UC can range from mild to extreme and vary from individual to individual. They can also change over time, when the symptoms are troublesome, with periods of recovery where a person has good health and no symptoms, alternating with relapses or flare-ups.

Ulcerative Colitis Market Key Facts
• The total prevalent population of Ulcerative Colitis in the 7MM in 2022 was ~2,223,000. These cases are expected to rise by 2032.
• In EU4 and the UK, in 2022, there were a total of ~1,024,000 prevalent cases and ~740,000 diagnosed prevalent cases of Ulcerative Colitis.
• The total diagnosed cases of Ulcerative Colitis in the 7MM were ~1,615,100 in 2022.
• In the 7MM, ~45% mild and ~55% moderate-to-severe cases of Ulcerative Colitis were observed in 2022.
• In the 7MM, the United States reported the highest prevalent cases of Ulcerative Colitis, i.e., ~1,026,000 which accounted for nearly 46% of the total 7MM cases, in the year 2022.
• Among the EU4 and the UK, the highest number of cases of Ulcerative Colitis was in Germany, i.e. ~357,000 cases in 2022.

Get a Detailed Overview of the Evolving Ulcerative Colitis Market Trends @
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ulcerative Colitis Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Ulcerative Colitis therapies in the market. It also provides a detailed assessment of the Ulcerative Colitis market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete details of the market trend for each marketed Ulcerative Colitis drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How the Ulcerative Colitis Market Will Grow by 2032 @
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ulcerative Colitis Epidemiology
The epidemiology section covers detailed insights into the historical, and current Ulcerative Colitis patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Ulcerative Colitis Epidemiology Segmented as -
• Total Prevalent Cases of Ulcerative Colitis in the 7MM [2019-2032]
• Severity-specific Cases of Ulcerative Colitis in the 7MM [2019-2032]
• Total Diagnosed Cases of Ulcerative Colitis in the 7MM [2019-2032]
• Age-specific Cases of Ulcerative Colitis in the 7MM [2019-2032]

Get Key Insights Into the Evolving Ulcerative Colitis Epidemiology Trends @

Ulcerative Colitis Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ulcerative Colitis market or expected to be launched during the study period. The analysis covers the market share by Ulcerative Colitis drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Ulcerative Colitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities in the Ulcerative Colitis Market @
https://www.delveinsight.com/sample-request/ulcerative-colitis-uc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ulcerative Colitis Therapeutics Assessment
A variety of treatment options may help the patient remain in control of the condition and lead a complete and rewarding life, but there is no proven cure for Ulcerative Colitis and flare-ups may recur. Medications like Aminosalicylates, Corticosteroids, Immunomodulators, biological therapies, Janus kinase (JAK) inhibitors, and S1P receptor modulators can suppress the inflammation of the colon and allow for tissues to heal.

Previously, the treatment goal for Ulcerative Colitis was to achieve clinical remission, however, in the past few years, the focus has now shifted to the induction of mucosal healing. For decades, mucosal healing was equated with endoscopic healing. The most significant shift is that histology has been included in the definition of mucosal healing for a few years. As a result, mucosal healing is generally defined as endoscopic plus histologic healing. Several companies are also shifting their focus towards mucosal healing.

Several major pharma and biotech companies are developing therapies for Ulcerative Colitis. Currently, Gilead Sciences is leading the therapeutics market with its Ulcerative Colitis drug candidates in the most advanced stage of clinical development.

Leading Companies in the Ulcerative Colitis Therapeutics Market Include
Eli Lilly and Company, Lipid Therapeutics, Hoffmann-La Roche, Arena Pharmaceuticals, InDex Pharmaceuticals, EA Pharma, Theravance Biopharma, Boehringer Ingelheim, Janssen Research & Development, Lycera, LG Chem, Iltoo Pharma, Immunic, Hutchison Medipharma, Tianjin Hemay Pharmaceutical, GlaxoSmithKline, Galapagos, Celgene, Gossamer Bio, Eisai, UCB, Suzhou Connect Biopharmaceuticals, Landos Biopharma, Seres Therapeutics, Abivax, Genentech, ParaTech A/S, I-Mab Biopharma, Sublimity Therapeutics Holdco, Reistone Biopharma, Qu Biologics, PurGenesis Technologies, Protagonist Therapeutics, Pfizer, Palobiofarma, Novartis Pharmaceuticals, Bristol-Myers Squibb, Bridge Biotherapeutics, Amgen, Allergan, Applied Molecular Transport, AbGenomics International, Protalix BioTherapeutics, LTT Bio-Pharma Co Ltd, Dongwha pharma, Seres Therapeutics, Innovation Pharmaceuticals, Holy Stone Healthcare, SLA Pharma, OSE Immunotherapeutics, Bridge Biotherapeutics, Mitsubishi Tanabe Pharma, Sterna Biologicals, Mesoblast, Oncostellae, First Wave Bio, Oppilan Pharma, NeuClone, Morphic Therapeutic, Metacrine, LG Chem, Koutif Therapeutics, Kiniksa Pharmaceuticals, Avaxia Biologics, Algernon Pharmaceuticals, Akeso Biopharma, Kaleido Biosciences, Rebiotix, Prometheus Biosciences, PNB Vesper Life Science, Pandion Therapeutics, Palatin Technologies, Theravance Biopharma, VHsquared, Seres Therapeutics, Hoffmann-La Roche, Provention Bio, Bacainn Therapeutics, Landos Biopharma, Bristol-Myers Squibb, Janssen Research & Development, GlaxoSmithKline, Assembly Biosciences, NuBiyota, and many others.

Emerging and Marketed Ulcerative Colitis Therapies Covered in the Report Include
• Etrasimod: Pfizer
• Skyrizi (Risankizumab): AbbVie
• Mirikizumab (LY-3074828): Eli Lilly and Company
• Etrasimod: Arena Pharmaceuticals
• Tremfya (Guselkumab): Janssen (Johnson & Johnson)
• SHR0302: Reistone Biopharma
• BT-11: Landos Biopharma
And Many More

Learn More About the Emerging Therapies and key Companies in the Ulcerative Colitis Therapeutics Market @
https://www.delveinsight.com/sample-request/ulcerative-colitis-uc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Ulcerative Colitis Competitive Intelligence Analysis
4. Ulcerative Colitis Market Overview at a Glance
5. Ulcerative Colitis Background and Overview
6. Ulcerative Colitis Patient Journey
7. Ulcerative Colitis Epidemiology and Patient Population
8. Ulcerative Colitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Ulcerative Colitis Unmet Needs
10. Key Endpoints of Ulcerative Colitis Treatment
11. Ulcerative Colitis Marketed Products
12. Ulcerative Colitis Emerging Therapies
13. Ulcerative Colitis Seven Major Market Analysis
14. Attribute Analysis
15. Ulcerative Colitis Market Outlook (7 major markets)
16. Ulcerative Colitis Access and Reimbursement Overview
17. KOL Views on the Ulcerative Colitis Market.
18. Ulcerative Colitis Market Drivers
19. Ulcerative Colitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/ulcerative-colitis-uc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market

Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market

Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market

Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market

Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market

Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market

Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market

Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market

Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market

Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market

Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market

Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market

Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.